Coronavirus Update - 24th June 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual.

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Formulation Development

We combine formulation development with physical characterisation and analytical method development. The team works together to determine how best to formulate APIs for both non-clinical and clinical applications. We have the flexibility to overcome challenges in development processes seamlessly, delivering speed alongside increased quality.